We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+18.28%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$648M
AUM Growth
-$71.9M
Cap. Flow
-$156M
Cap. Flow %
-24%
Top 10 Hldgs %
21.35%
Holding
491
New
67
Increased
62
Reduced
186
Closed
160

Top Buys

Rank Stock Value
1
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$9.4M
2
BELFB
Bel Fuse Inc Class B
BELFB
+$8.88M
3
TRS icon
TriMas Corp
TRS
+$4.94M
4
CNNE icon
Cannae Holdings
CNNE
+$4.12M
5
XOM icon
ExxonMobil
XOM
+$2.62M

Top Sells

Rank Stock Value
1
MMS icon
Maximus
MMS
+$8.25M
2
DEN
Denbury Inc.
DEN
+$5.75M
3
IBTD
iShares iBonds Dec 2023 Term Treasury ETF
IBTD
+$4.73M
4
VVV icon
Valvoline
VVV
+$3.8M
5
NOG icon
Northern Oil and Gas
NOG
+$3.52M

Sector Composition

Rank Sector Weight
1 Technology 22.66%
2 Consumer Discretionary 18.68%
3 Industrials 13.97%
4 Healthcare 11.28%
5 Financials 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXN icon
476
Texas Instruments
TXN
$248B
– –
-2,162
Closed -$344K
V icon
477
Visa
V
$702B
– –
-2,606
Closed -$599K
VRTX icon
478
Vertex Pharmaceuticals
VRTX
$125B
– –
-1,092
Closed -$380K
VYX icon
479
NCR Voyix
VYX
$1.19B
– –
-81,027
Closed -$1.34M
WDAY icon
480
Workday
WDAY
$40.8B
– –
-1,535
Closed -$330K
WHF icon
481
WhiteHorse Finance
WHF
$140M
– –
-27,078
Closed -$346K
WMT icon
482
Walmart Inc
WMT
$901B
– –
-8,316
Closed -$443K
XENE icon
483
Xenon Pharmaceuticals
XENE
$6.22B
– –
-38,326
Closed -$1.31M
ZGN icon
484
Zegna
ZGN
$3.98B
– –
-81,273
Closed -$1.13M
ZTS icon
485
Zoetis
ZTS
$32.8B
– –
-1,511
Closed -$263K
HCVI
486
DELISTED
Hennessy Capital Investment Corp. VI Class A Common Stock
HCVI
– –
-299,505
Closed -$3.09M
ITCI
487
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-25,333
Closed -$1.32M
SBOW
488
DELISTED
SilverBow Resources, Inc.
SBOW
– –
-12,232
Closed -$438K
IBTD
489
DELISTED
iShares iBonds Dec 2023 Term Treasury ETF
IBTD
– –
-190,385
Closed -$4.73M
AVTA
490
DELISTED
Avantax, Inc. Common Stock
AVTA
– –
-33,691
Closed -$862K
DEN
491
DELISTED
Denbury Inc.
DEN
– –
-58,656
Closed -$5.75M
16 17 18 19
20

Similar funds

SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $810M AUM 16.24% 1-Year Est. Return
SSG
Summit Securities Group New York $810M AUM 27.35% 1-Year Est. Return
BWS
Buck Wealth Strategies Denver, Colorado $810M AUM 10.81% 1-Year Est. Return

Advisory Research's Q4 2023 Portfolio in Review

As of Q4 2023, Advisory Research held 491 positions worth $648M, down 10% from $720M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Advisory Research withdrew a net $156M in Q4 2023, closing 160 positions and reducing 186 holdings. Its most notable exit was Denbury Inc., an estimated $5.75M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Advisory Research opened a new position in TriMas Corp worth $5.06M.

  • Advisory Research's largest Q4 2023 buy was TriMas Corp: 199,840 shares worth $5.06M.
  • Advisory Research added most to iShares MSCI ACWI ETF in Q4 2023, an estimated $9.4M increase.
  • Advisory Research's biggest Q4 2023 reduction was Maximus, cutting an estimated $8.25M.
  • Advisory Research fully exited Denbury Inc. in Q4 2023, selling an estimated $5.75M.
  • Advisory Research's ten largest holdings make up 21% of its $648M portfolio in Q4 2023.
  • Advisory Research opened 67 new positions and closed 160 in Q4 2023.
  • Advisory Research's portfolio value fell 10% quarter-over-quarter to $648M.

Based on Advisory Research's 13F filing for Q4 2023, filed 13 Feb 2024.